Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Endo, F.
Right arrow Articles by Matsuda, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Endo, F.
Right arrow Articles by Matsuda, I.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:1605S-1609S, June 2004


Supplement: 3rd Amino Acid Workshop

Clinical Manifestations of Inborn Errors of the Urea Cycle and Related Metabolic Disorders during Childhood1

Fumio Endo2, Toshinobu Matsuura, Kaede Yanagita and Ichiro Matsuda

Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860, Japan

2 To whom correspondence should be addressed. E-mail: fendo{at}kumamoto-u.ac.jp.

Various disorders cause hyperammonemia during childhood. Among them are those caused by inherited defects in urea synthesis and related metabolic pathways. These disorders can be grouped into two types: disorders of the enzymes that comprise the urea cycle, and disorders of the transporters or metabolites of the amino acids related to the urea cycle. Principal clinical features of these disorders are caused by elevated levels of blood ammonium. Additional disease-specific symptoms are related to the particular metabolic defect. These specific clinical manifestations are often due to an excess or lack of specific amino acids. Treatment of urea cycle disorders and related metabolic diseases consists of nutritional restriction of proteins, administration of specific amino acids, and use of alternative pathways for discarding excess nitrogen. Although combinations of these treatments are extensively employed, the prognosis of severe cases remains unsatisfactory. Liver transplantation is one alternative for which a better prognosis is reported.


KEY WORDS: • urea cycle disorders • hyperammonemia • carbamyl phosphate synthetase • ornithine transcarbamylase




This article has been cited by other articles:


Home page
Eukaryot CellHome page
J.-Y. Song, K.-D. Kim, and J.-H. Roe
Thiol-Independent Action of Mitochondrial Thioredoxin To Support the Urea Cycle of Arginine Biosynthesis in Schizosaccharomyces pombe
Eukaryot. Cell, December 1, 2008; 7(12): 2160 - 2167.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M.-C. Chiang, H.-M. Chen, Y.-H. Lee, H.-H. Chang, Y.-C. Wu, B.-W. Soong, C.-M. Chen, Y.-R. Wu, C.-S. Liu, D.-M. Niu, et al.
Dysregulation of C/EBP{alpha} by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease
Hum. Mol. Genet., March 1, 2007; 16(5): 483 - 498.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by American Society for Nutrition